# Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

> **NCT03281954** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **NSABP Foundation Inc** · enrollment: 1550 (actual)

## Conditions studied

- Triple Negative Breast Cancer

## Interventions

- **DRUG:** Placebo
- **DRUG:** Atezolizumab

## Key facts

- **NCT ID:** NCT03281954
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-12-19
- **Primary completion:** 2024-12-31
- **Final completion:** 2027-11-30
- **Target enrollment:** 1550 (ACTUAL)
- **Last updated:** 2024-04-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03281954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03281954, "Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03281954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*